ACA
ACER

Avoro Capital Advisors’s Acer Therapeutics Inc ACER Stock Holding History

Avoro Capital Advisors’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-150,000
Closed -$3.02M – 39
2018
Q4 		$3.02M Sell
150,000
-130,000
-46% -$2.99M 0.18% 31
2018
Q3 		$8.63M Buy
+280,000
New +$7.5M 0.4% 31

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Avoro Capital Advisors's ACER Position: Q1 2019 in Review

Avoro Capital Advisors sold out of Acer Therapeutics Inc (ACER) in Q1 2019, closing a stake of 150,000 shares — an estimated $3.02M sold.

Avoro Capital Advisors first reported a position in ACER in Q3 2018 and held it in 2 quarters. The position peaked at $8.63M in Q3 2018. 34 funds tracked by Wall St. Rank hold ACER as of Q1 2019.

  • Avoro Capital Advisors reported no remaining Acer Therapeutics Inc position as of Q1 2019 after selling out during the quarter.
  • Avoro Capital Advisors sold 150,000 Acer Therapeutics Inc shares in Q1 2019, an estimated $3.02M.
  • Avoro Capital Advisors first reported a position in Acer Therapeutics Inc in Q3 2018 and held it in 2 quarters.
  • Avoro Capital Advisors's Acer Therapeutics Inc position peaked at $8.63M in Q3 2018.
  • 34 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q1 2019.

Based on Avoro Capital Advisors's 13F filing for Q1 2019, filed 15 May 2019.